Evaluating the Evolving Real‐World Adverse Events of GLP ‐ 1RAs Using FDA Adverse Event Reporting System ( FAERS )

Documents similaires

• Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS)
  par: Jiaqi Guo, et autres
  Publié: (2026)
• Descriptive Analysis of Ranolazine Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  par: Nehad Jaser Ahmed
  Publié: (2026)
• Descriptive Analysis of DALTEPARIN Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  par: Nehad Jaser Ahmed
  Publié: (2026)
• DOFETILIDE Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  par: Nehad Jaser Ahmed
  Publié: (2026)
• Prazosin Adverse Events: A Descriptive Analysis of the FDA Adverse Event Reporting System (FAERS)
  par: Nehad Jaser Ahmed
  Publié: (2026)